Cargando…
Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial
BACKGROUND: Regorafenib, a multikinase inhibitor, causes a high frequency of hand-foot skin reactions (HFSRs). The present study evaluated the efficacy of topical aluminum chloride, a perspiration suppressant, in reducing the severity of hand-foot skin reactions (HFSRs) caused by regorafenib. METHOD...
Autores principales: | Nishizawa, Aya, Shinozaki, Eiji, Wakatsuki, Takeru, Satoh, Takahiro, Yamazaki, Naoya, Oyamada, Shunsuke, Ariyoshi, Keisuke, Kihara, Kota, Tsuboi, Masahiro, Yamaguchi, Kensei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157908/ https://www.ncbi.nlm.nih.gov/pubmed/37142953 http://dx.doi.org/10.1186/s12885-023-10864-9 |
Ejemplares similares
-
Association Between Regorafenib Dose and Efficacy Against Metastatic
Colorectal Cancer in a Real-World Setting
por: Hatori, Masahiro, et al.
Publicado: (2021) -
Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer
por: Suenaga, Mitsukuni, et al.
Publicado: (2016) -
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
por: Kawakami, Kazuyoshi, et al.
Publicado: (2019) -
Regorafenib-Induced Hand–Foot Skin Reaction Is More Severe on the Feet Than on the Hands
por: Nonomiya, Yuma, et al.
Publicado: (2019) -
Multicentre single-arm phase II trial evaluating the safety and effiCacy of Panitumumab and iRinOtecan in NeoRAS Wild-type mEtaStatic colorectal cancer patientS (C-PROWESS trial): study protocol
por: Osumi, Hiroki, et al.
Publicado: (2022)